Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single and Multiple Ascending Doses, Food-effect Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 Tablets in Healthy Chinese Participants

NCT07522970 is registered in ClinicalTrials.gov with LinGang Laboratory as lead sponsor.

NCT NCT07522970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07522970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single and Multiple Ascending Doses, Food-effect Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 Tablets in Healthy Chinese Participants
Lead sponsor
LinGang Laboratory
Phase
Phase 1
Overall status
Recruiting
Start date
April 20, 2026
Completion date
September 10, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers